Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Postoperative adjuvant chemotherapy (AC) for poor responders to neoadjuvant chemoradiotherapy (nCRT) remains debatable among patients with locally advanced rectal cancer (LARC), necessitating biomarkers to accurately predict the benefits of AC. This study aimed to develop a patient‐derived tumor org...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Weisong, Wang, Ting, Yao, Jiaxin, Wu, Wei, Chen, Dexin, Yan, Botao, Dong, Xiaoyu, Tang, Yuting, Zeng, Yunli, He, Yueyu, Cao, Peihua, Shao, Fangyuan, Huang, Wenhua, Deng, Chuxia, Yan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658544/
https://www.ncbi.nlm.nih.gov/pubmed/38023722
http://dx.doi.org/10.1002/btm2.10586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658544/
https://www.ncbi.nlm.nih.gov/pubmed/38023722
http://dx.doi.org/10.1002/btm2.10586

Ejemplares similares